BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23159218)

  • 1. Emerging concepts in the management and treatment of osteonecrosis of the jaw.
    Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2013 Feb; 25(1):11-20, v. PubMed ID: 23159218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed].
    Yoneda T
    Clin Calcium; 2014 Mar; 24(3):407-15. PubMed ID: 24576938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bisphosphonate-related osteonecrosis of the jaw].
    Atanes-Bonome P; Atanes-Bonome A; Ríos-Lage P; Atanes-Sandoval AD
    Semergen; 2014 Apr; 40(3):143-8. PubMed ID: 24001573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention and treatment of bisphosphonate-induced jaw bone osteonecrosis. II].
    Fogorv Sz; 2014 Sep; 107(3):106-7. PubMed ID: 25509512
    [No Abstract]   [Full Text] [Related]  

  • 5. FPIN's clinical inquiries. Risks of bisphosphonate use.
    Scott MA; Meadowcraft L; Skolnik D
    Am Fam Physician; 2013 Nov; 88(10):697, 702. PubMed ID: 24364486
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiresorptives and osteonecrosis of the jaw.
    Yamashita J; McCauley LK
    J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):233-47. PubMed ID: 23040351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dental implications of bisphophonate-related osteonecrosis.
    Saldanha S; Shenoy VK; Eachampati P; Uppal N
    Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteonecrosis of the jaw as a serious adverse effect of bisphosphonate therapy and its indistinct etiopathogenesis.
    Gavrić M; Antić S; Jelovac DB; Zarev AI; Petrović MB; Golubović M; Antunović M
    Vojnosanit Pregl; 2014 Aug; 71(8):772-6. PubMed ID: 25181838
    [No Abstract]   [Full Text] [Related]  

  • 9. Bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
    Piccioli A
    Eur J Orthop Surg Traumatol; 2015 Jan; 25(1):29-37. PubMed ID: 24037511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in the research of bisphosphonate-associated osteonecrosis of the jaws].
    Ruan M; Ji T; Zhang CP
    Shanghai Kou Qiang Yi Xue; 2006 Dec; 15(6):663-7. PubMed ID: 17533726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The risk of bisphosphonate-related osteonecrosis of the jaw].
    Polymenidi I; Trombetti A; Carballo S
    Rev Med Suisse; 2014 Oct; 10(446):1930-4. PubMed ID: 25438377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-related osteonecrosis of the jaw: an overview.
    Ruggiero SL
    Ann N Y Acad Sci; 2011 Feb; 1218():38-46. PubMed ID: 20946580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamin D and bisphosphonate-related osteonecrosis of the jaw (BRONJ) ].
    Hokugo A
    Clin Calcium; 2012 Jan; 22(1):83-90. PubMed ID: 22201103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate-related osteonecrosis of the jaw.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
    SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of osteoclast modifiers on the oral cavity: a review for prescribers.
    Epstein MS; Epstein JB; Ephros HD
    Curr Opin Support Palliat Care; 2012 Sep; 6(3):337-41. PubMed ID: 22871978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of bisphosphonates in medical oncology and their association with jaw bone necrosis.
    Eid A; Atlas J
    Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):231-7. PubMed ID: 24794267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An office-based approach to the diagnosis and management of osteonecrosis.
    Ruggiero SL
    Atlas Oral Maxillofac Surg Clin North Am; 2013 Sep; 21(2):167-73. PubMed ID: 23981492
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
    Dupic G; Collangettes D; Dillies AF; Calvet L; Tournilhac O; Bay JO; Mahammedi H
    Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Medication-Related Osteonecrosis of the Jaw.
    Williams WB; O'Ryan F
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):517-25. PubMed ID: 26515735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.